Search Results - "Aldemerdash, A"

Persistent left superior vena cava in patient with right atrial myxoma undergoing open heart surgery. A case report and review of literature by Elhamamsy, Mostafa, Aldemerdash, A, Zahran, F, Bakir, B, Alanazi, Nouf, Awadallah, Yasser, Haggag, Sami, Alshiekh, Mahmoud

“…Persistent left superior vena cava (PLSVC) is a rare and asymptomatic congenital cardiovascular anomaly. Being asymptomatic, PLSVC was usually discovered while…”
Get full text

Partial Splenectomy Versus Total Splenectomy in Sickle Cell Disease: A Systematic Review and Meta-Analysis by Roshdy, Merna Raafat, Botros, Mina, Mokhles, Abanoub, Aldemerdash, Mohamed A., Sabet, Haneen, Fahim, Bishoy, Hindawi, Mahmoud Diaa

“…Sickle cell disease (SCD) patients encounter various complications, such as acute splenic sequestration crisis and hypersplenism that may require splenectomy…”
Get full text

Evaluating the efficacy and safety of platelet-rich plasma injection for erectile dysfunction: a systematic review and meta-analysis of randomized controlled trials by Deabes, Mostafa, Deameh, Mohammad Ghassab, Bani Irshid, Baha' Aldeen, Al Darraji, Ali Hasan, Serag, Ibrahim, Almosilhy, Nereen A, Dwidar, Ahmed, Aldemerdash, Mohamed A, Shahin, Hatim Nasruldin

“…Platelet-rich plasma (PRP) is rich in factors that play a role in stem cell recruitment, inflammation modulation, and angiogenesis. With numerous preclinical…”
Get full text

PCV94 PRESCRIBING PATTERNS FOR PATIENTS WITH HEART FAILURE AT DISCHARGE IN A TERTIARY HOSPITAL, IN RIYADH by Alsharafi, A., Almodaimegh, H., Bahamam, N., Alharbi, B., Alawwad, M., Aldemerdash, A.

Get full text

Multidrug-Resistant and Extensively Drug-Resistant Enterobacteriaceae: Prevalence, Treatments, and Outcomes - A Retrospective Cohort Study by Alkofide, Hadeel, Alhammad, Abdullah M, Alruwaili, Alya, Aldemerdash, Ahmed, Almangour, Thamer A, Alsuwayegh, Aseel, Almoqbel, Daad, Albati, Aljohara, Alsaud, Aljohara, Enani, Mushira

“…Drug-resistant gram-negative bacteria (GNB) are a global public health threat, especially in intensive care units (ICU). This study explored the prevalence of…”
Get full text

Adherence to Statin Therapy and Attainment of LDL Cholesterol Goal Among Patients with Type 2 Diabetes and Dyslipidemia by Alwhaibi, Monira, Altoaimi, Maha, AlRuthia, Yazed, Meraya, Abdulkarim M, Balkhi, Bander, Aldemerdash, Ahmed, Alkofide, Hadeel, Alhawassi, Tariq M, Alqasoumi, Abdulmajeed, Kamal, Khalid M

“…Statins are widely utilized antidyslipidemics with a proven track record of safety and efficacy. However, the efficacy of these therapeutic agents hinges on…”
Get full text

Knowledge, Attitude, and Practice Towards COVID-19 Among Pharmacists: A Cross-Sectional Study by AlRasheed, Maha M, AlShahrani, Amani H, AlMuhaini, Sara A, AlKofde, Hadeel A, Alhawassi, Tariq M, Aldemerdash, Ahmed, Alhaj, Omar A, Bragazzi, Nicola L, Jahrami, Haitham A

“…Purpose: The COVID-19 outbreak has caused governments to put pandemic-related guidelines requiring compliance and understanding by healthcare professionals to…”
Get full text

IBCL-506 Safety and Efficacy of Ibritumomab Tiuxetan Versus Rituximab in Newly Diagnosed and Relapsed Patients With Non-Hodgkin Lymphoma: A Systematic Review and Meta-Analysis by Albakri, Khaled, Khater, Bashar, Aldemerdash, Mohamed A., Nasruldin Shahin, Hatim, Saleh, Othman, Al-Hawi, Omar, Aldemerdash, Mohamed A., Alnajjar, Roa'a, Khaity, Abdulrhman, Al-Hawi, Omar

“…Rituximab is the standard therapy after chemotherapy induction for newly diagnosed non-Hodgkin lymphoma (NHL) patients. Recent evidence suggests…”
Get full text

IBCL-523 Comparative Efficacy, Safety, and Cost-Effectiveness of Subcutaneous Versus Intravenous Rituximab in Non-Hodgkin Lymphoma: A Systematic Review and Meta-Analysis by Albakri, Khaled, Khater, Bashar, Aldemerdash, Mohamed A., Nasruldin Shahin, Hatim, Aldemerdash, Ahmed, Saleh, Othman, Nabeel Alsafuti, Mohammad, Alnajjar, Roa'a, Khaity, Abdulrhman, Ammari, Omar

“…Rituximab is considered a mainstay of treatment for non-Hodgkin lymphoma (NHL) that is usually given intravenously. A subcutaneous formulation is proposed as…”
Get full text

Comparative Efficacy, Safety, and Cost-Effectiveness of Subcutaneous Versus Intravenous Rituximab in Non-Hodgkin Lymphoma: A Systematic Review and Meta-Analysis by Albakri, Khaled, Khater, Bashar, Aldemerdash, Mohamed A., Nasruldin Shahin, Hatim, Aldemerdash, Ahmed, Saleh, Othman, Nabeel Alsafuti, Mohammad, Alnajjar, Roa'a, Khaity, Abdulrhman, Ammari, Omar

Get full text

Safety and Efficacy of Ibritumomab Tiuxetan Versus Rituximab in Newly Diagnosed and Relapsed Patients With Non-Hodgkin Lymphoma: A Systematic Review and Meta-Analysis by Albakri, Khaled, Khater, Bashar, Aldemerdash, Mohamed A., Nasruldin Shahin, Hatim, Saleh, Othman, Al-Hawi, Omar, Abdallah, Mohamed, Alnajjar, Roa'a, Khaity, Abdulrhman, Ammari, Omar

Get full text

Comparative Efficacy, Safety, and Cost-Effectiveness of Subcutaneous Versus Intravenous Rituximab in Non-Hodgkin Lymphoma: A Systematic Review and Meta-Analysis by Albakri, Khaled, Khater, Bashar, Aldemerdash, Mohamed A., Nasruldin Shahin, Hatim, Aldemerdash, Ahmed, Saleh, Othman, Nabeel Alsafuti, Mohammad, Alnajjar, Roa'a, Khaity, Abdulrhman, Ammari, Omar

Get full text

Persistent left superior vena cava in patient with right atrial myxoma undergoing open heart surgery. A case report and review of literature by Elhamamsy, Mostafa, Aldemerdash, A, Zahran, F, Bakir, B M, Alanazi, Nouf A, Awadallah, Yasser Abdulrahman, Haggag, Sami Ibrahim, Alshiekh, Mahmoud Salama

Get full text